| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2180839
Max Phase: Preclinical
Molecular Formula: C16H28N4O
Molecular Weight: 292.43
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(C)(C)c1cc(NC(=O)CCCN2CCCCC2)[nH]n1
Standard InChI: InChI=1S/C16H28N4O/c1-16(2,3)13-12-14(19-18-13)17-15(21)8-7-11-20-9-5-4-6-10-20/h12H,4-11H2,1-3H3,(H2,17,18,19,21)
Standard InChI Key: OGPREQIZGSIMHW-UHFFFAOYSA-N
Associated Targets(Human)
HERG 29587 Activities
Acetylcholine receptor; alpha1/beta1/delta/gamma 501 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Neuronal acetylcholine receptor subunit alpha-3 93 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Serotonin 3a (5-HT3a) receptor 3366 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Neuronal acetylcholine receptor protein alpha-7 subunit 3047 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 292.43 | Molecular Weight (Monoisotopic): 292.2263 | AlogP: 2.91 | #Rotatable Bonds: 5 |
| Polar Surface Area: 61.02 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.72 | CX Basic pKa: 9.52 | CX LogP: 2.80 | CX LogD: 0.70 |
| Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.88 | Np Likeness Score: -1.81 |
References
| 1. Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M.. (2012) N-[5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): a medicinal chemistry effort toward an α7 nicotinic acetylcholine receptor agonist preclinical candidate., 55 (22): [PMID:23083093] [10.1021/jm3013568] |
Source
Source(1):